Skip to main content

What the FDA labels say about taking them together

Cobicistat and digoxin

Cobicistat's FDA label of February 10, 2026 names digoxin in its drug interactions section; the digoxin labels PlainMeds reads (3) do not name cobicistat. The cobicistat label: “When coadministering with digoxin, titrate the digoxin dose and monitor digoxin concentrations.”

Check it at the source: the cobicistat FDA label on DailyMed (effective February 10, 2026, Gilead Sciences, Inc.); the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.).

What does the cobicistat label say about digoxin?

Cobicistat label, drug interactions

Concomitant Drug Class/Drug Name: digoxin; Potential Effect ↑ = Increase, ↓ = Decrease, ↔ = No change: ↑ digoxin; Clinical Comment: When coadministering with digoxin, titrate the digoxin dose and monitor digoxin concentrations.

Source: FDA drug label (Tybost), Gilead Sciences, Inc., effective February 10, 2026 (SPL set 3784c35c-e87f-410c-900b-8fd6313c6010), via openFDA; the full label on DailyMed

What does the digoxin label say about cobicistat?

Digoxin's label (effective December 5, 2024) and its 2 other brand-application labels do not name cobicistat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cobicistat generic labelers
26Digoxin generic labelers
CobicistatDigoxin
Labeled forHIVHeart failure, Atrial fibrillation
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.133 per tablet 125 mcg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?